Lv11
70 积分 2025-03-13 加入
Incorporating Dynamic Pricing in Cost-Effectiveness Analysis: Are Known Unknowns Valuable?
17小时前
待确认
Chinese utility weights for the EORTC cancer-specific utility instrument QLU-C10D
20天前
已完结
The Japan Glaucoma Society guidelines for glaucoma 5th edition
1个月前
已完结
Incidence of gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs): An updated systematic review of population‐based reports from 2010 to 2023
1个月前
已完结
Cost‐effectiveness and quality‐of‐life assessment of GM‐CSF as an adjunct to intensive remission induction chemotherapy in elderly patients with acute myeloid leukaemia
1个月前
已完结
Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multi-center Cohort Study
1个月前
已完结
A safety and efficacy study of allogeneic haematopoietic stem cell transplantation for refractory and relapsed T‐cell acute lymphoblastic leukaemia/lymphoblastic lymphoma patients who achieved complete remission after autologous CD7 chimeric antigen receptor T‐cell therapy
1个月前
已完结
Cost-effectiveness of Enasidenib versus conventional care for older patients with IDH2- mutant refractory/relapsed AML
1个月前
已完结
[Chinese expert consensus on diagnosis and treatment of pulmonary nodules(2024)]
1个月前
已完结
Anlotinib plus Epirubicin Followed by Anlotinib Maintenance as First-line Treatment for Advanced Soft-tissue Sarcoma: An Open-label, Single-arm, Phase II Trial
1个月前
已完结
皖公网安备34019202002308
